Methylpiperazine

Methylpiperazine

SCHEMBL5498097

CC(C=CC(=O)O)=Cc1ccc2c(c1)OCO2.CN1CCNCC1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.56
CYP1A2 P05177 2/20 0.50
HSD17B10 Q99714 1/20 0.50
MAOB P27338 3/20 0.47
KDM4E B2RXH2 5/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TRPV1 Q8NER1 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 4/20 0.46
KMT2A Q03164 3/20 0.46
TRPM8 Q7Z2W7 1/20 0.46
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5808562 0.88 CYP1A2 (0.62) CYP1A2HSD17B10KDM4ENPC1RAB9A
SCHEMBL5487655 0.88 CYP1A2 (0.62) CYP1A2HSD17B10KDM4ENPC1RAB9A
SCHEMBL5487654 0.88 CYP1A2 (0.62) CYP1A2HSD17B10KDM4ENPC1RAB9A
Methylpiperazine SCHEMBL5496267 0.87 HPGD (0.52) HPGDCYP1A2HSD17B10MAOBKDM4E
SCHEMBL5494050 0.85 CYP1A2 (0.49) HPGDCYP1A2HSD17B10MAOBKDM4E
Pyrrole SCHEMBL5494473 0.84 CYP1A2 (0.53) HPGDCYP1A2HSD17B10KDM4ENPC1
SCHEMBL5493158 0.80 RAB9A (0.56) HPGDCYP1A2HSD17B10MAOBKDM4E
Methylpiperazine SCHEMBL5820730 0.80 MCHR1 (0.40) HPGDCYP1A2MAOBCYP3A4CYP2C9
SCHEMBL5494471 0.76 MAOB (0.72) HPGDCYP1A2HSD17B10MAOBKDM4E
SCHEMBL15513969 0.75 CYP1A2 (0.50) HPGDCYP1A2HSD17B10KDM4ETRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073860-B2 Aromatic amides as potentiators of bioefficacy of anti-infective drugs COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-07-07 US claimed
US-20140073595-A1 AROMATIC AMIDES AS POTENTIATORS OF BIOEFFICACY OF ANTI-INFECTIVE DRUGS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2014-03-13 US claimed
US-8580752-B2 Aromatic amides as potentiators of bioefficacy of anti-infective drugs COUNCIL OF SCIENTITIC AND INDUSTRIAL RESEARCH (IN) 2013-11-12 US claimed
US-20070004645-A1 Aromatic amides as potentiators of bioefficacy of anti-infective drugs COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-01-04 US claimed
US-9073860-B2 Aromatic amides as potentiators of bioefficacy of anti-infective drugs COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-07-07 US disclosed
US-20140073595-A1 AROMATIC AMIDES AS POTENTIATORS OF BIOEFFICACY OF ANTI-INFECTIVE DRUGS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2014-03-13 US disclosed
US-8580752-B2 Aromatic amides as potentiators of bioefficacy of anti-infective drugs COUNCIL OF SCIENTITIC AND INDUSTRIAL RESEARCH (IN) 2013-11-12 US disclosed
US-20070004645-A1 Aromatic amides as potentiators of bioefficacy of anti-infective drugs COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140073595-A1 AROMATIC AMIDES AS POTENTIATORS OF BIOEFFICACY OF ANTI-INFECTIVE DRUGS DDC, APEH, AADAC HPGD 115/4885CYP1A2 69/4885HSD17B10 620/4885
US-20070004645-A1 Aromatic amides as potentiators of bioefficacy of anti-infective drugs DDC, APEH, AADAC HPGD 115/4885CYP1A2 69/4885HSD17B10 620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.